Moldtek Packaging Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook

Fri Apr 24 2026

Moldtek Packaging (MOLDTKPAC) Q4 results for FY26 are expected in May 2026. With Q3 FY26 revenue of Rs 285 Cr and PAT of Rs 35 Cr as the base, the street is watching closely for margin trajectory and management guidance on FY27 demand.

Get Free SEBI-Registered Research on Moldtek Packaging â€” Click Here

Table of Contents

Moldtek Packaging Q4 FY26 Earnings Preview â€” What to Expect

India’s specialty chemicals sector is in recovery mode in Q4 FY26, with global inventory destocking cycles ending and China Plus One sourcing creating new export order flows for Indian manufacturers with quality approvals.

Moldtek Packaging Q4 Results 2026 â€” Date and Key Estimates

Parameter	Q3 FY26 Actual	Q4 FY26 Estimate	YoY Growth
Revenue (Rs Cr)	285	308	+8%
PAT (Rs Cr)	35	40	+14%
EBITDA Margin	—	13.0%	Improvement expected
Results Date	—	May 2026	—
Dividend History	Rs 5.00 per share
Dividend Expectation	Rs 7.00 final dividend expected

Estimates based on analyst consensus as of April 2026. Actual results may vary. Verify before investing.

Track Moldtek Packaging live price, FII/DII activity and fundamentals on Univest Screener

5 Reasons Moldtek Packaging Q4 Results Could Beat Estimates

Export Demand Recovery Post Destocking

Global chemical destocking cycles are drawing to a close. European and US buyers are resuming regular procurement from Indian specialty chemical suppliers, with order flow normalising across agrochemical intermediates and fine chemicals.

Agrochemical Market Uptick

Global agrochemical demand recovery is benefiting Indian manufacturers of intermediates and technical actives as channel inventories normalise and planting season demand picks up globally.

China Plus One Sourcing Shift

Continued strategic diversification away from China by global chemical multinationals is creating new long-term supply agreements for Indian players with REACH and other regulatory approvals.

Capacity Utilisation Improvement

New capacities commissioned in FY24-25 are now ramping up, improving fixed cost absorption and enabling meaningful operating leverage on recovering volumes.

Product Mix Premiumisation toward CDMO

Companies focusing on fine chemicals, CDMO services and performance materials are seeing better realisation and superior margins compared to commodity chemical peers.

5 Key Risks to Watch in Moldtek Packaging Q4 Results

China Dumping Risk

Chinese chemical producers with excess capacity may resort to aggressive pricing in global markets, pressuring Indian exporters on both volume and margins.

Agrochemical Market Cyclicality

Oversupply or poor monsoon seasons can rapidly reverse agrochemical demand conditions for intermediates and actives manufacturers.

Environmental Compliance Costs

Stringent REACH standards in Europe and domestic environmental regulations add compliance and capital investment costs.

Customer Concentration

Dependence on a few large global clients creates revenue vulnerability to sourcing strategy shifts or relationship disruptions.

Energy Cost Sensitivity

Specialty chemical manufacturing is energy-intensive; power and fuel cost fluctuations directly impact production margins.

Analyst Ratings and Target Price for Moldtek Packaging

Brokerage	Rating	Key Thesis
ICICI Direct	Buy	Export recovery and China Plus One structural benefit
Motilal Oswal	Neutral	Gradual recovery; watch margin trajectory
JM Financial	Buy	Volume ramp-up and operating leverage materialising

Analyst ratings are for informational purposes only and subject to change. Not investment advice.

Moldtek Packaging share price (MOLDTKPAC) is trading near Rs 298 with a market capitalisation of approximately Rs 2,150 Cr. Track the stock on Univest Screener for live price and fundamental data.

Q4 Results 2026 Calendar â€” Key Dates to Track

Company	Expected Results Date
Moldtek Packaging	May 2026
TCS	April 2026
Infosys	April 2026

Stay updated on all Q4 FY26 earnings at Univest Blogs. For TCS results see TCS Q4 Results 2026 and for Infosys see Infosys Q4 Results 2026.

How to Invest in Moldtek Packaging Based on Q4 Results

Before investing in Moldtek Packaging based on Q4 results, consider the following approach: review the actual revenue and PAT versus analyst estimates, listen to the management earnings call for FY27 guidance, assess whether the EBITDA margin trajectory is improving or deteriorating, and check FII/DII activity patterns post-results. A beat on estimates with positive guidance is typically a bullish signal; a miss with downgraded guidance may indicate further correction risk.

Subscribe to Univest Pro for SEBI-registered entry, target and stop-loss levels on Moldtek Packaging â€” Click Here

Frequently Asked Questions â€” Moldtek Packaging Q4 Results 2026

Q: When will Moldtek Packaging announce Q4 FY26 results?

Moldtek Packaging (MOLDTKPAC) is expected to announce Q4 FY26 results in May 2026. The exact board meeting date will be communicated via BSE/NSE exchange filing. Track the date on Univest Screener.

Q: What is the revenue estimate for Moldtek Packaging Q4 FY26?

Analyst consensus estimates Moldtek Packaging Q4 FY26 revenue at approximately Rs 308 Cr, representing approximately 8% year-on-year growth. The actual number will depend on sector demand trends and execution in the quarter.

Q: What PAT is expected for Moldtek Packaging in Q4 FY26?

Estimated PAT for Moldtek Packaging Q4 FY26 is approximately Rs 40 Cr, up approximately 14% year-on-year. Margin expansion from operating leverage and input cost moderation are the primary drivers of profit growth expectations.

Q: Will Moldtek Packaging declare a dividend in Q4 FY26?

Historical dividend pattern for Moldtek Packaging: Rs 5.00 per share. For Q4 FY26, Rs 7.00 final dividend expected. Dividend declarations are subject to board approval at the time of results.

Q: What is the current share price and market cap of Moldtek Packaging?

Moldtek Packaging (MOLDTKPAC) is currently trading at approximately Rs 298 with a market capitalisation of Rs 2,150 Cr. Track live price, volume and FII/DII data on Univest Screener.

Q: What are the key risks for Moldtek Packaging in Q4 FY26?

Key risks include: China Dumping Risk, Agrochemical Market Cyclicality, Environmental Compliance Costs. Investors should monitor management commentary on these risks in the Q4 earnings call.

Q: Is Moldtek Packaging a buy before Q4 results?

This article does not constitute investment advice. Whether to buy Moldtek Packaging before Q4 results depends on your risk appetite, existing portfolio exposure and entry price relative to fair value. Consult a SEBI-registered financial advisor before making any investment decision.

Q: How can I track Moldtek Packaging Q4 results live?

Track Moldtek Packaging Q4 FY26 results live on the Univest Screener, which provides real-time price updates, financial data and analyst research. Download the Univest iOS App or Android App for mobile alerts.

Disclaimer: Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Consult a SEBI-registered financial advisor before making any investment decisions. SEBI Registration: INH000012449.